Results 21 to 30 of about 493 (143)

Myasthenic crisis: report of 24 cases Crise miastênica: relato de 24 casos

open access: yesArquivos de Neuro-Psiquiatria, 2002
Myasthenic crisis (MC) is a life-threatening complication of myasthenia gravis (MG) with a high mortality rate. The aim of our study was to review the different therapeutics approaches in the treatment of MC and their impact in the final outcome.
Lineu Cesar Werneck   +4 more
doaj   +1 more source

Ruolo delle heat shock proteins nella patogenesi della miastenia gravis [PDF]

open access: yes, 2010
Myasthenia Gravis (MG) is an autoimmune disorder of the neuromuscolar junction mediated by specific antibodies to the nicotinic acetylcholine receptors. Several clinical and experimental studies have confirmed that the HSPs are involved in the process of
MARINO GAMMAZZA, Antonella, ZUMMO, Leila
core   +1 more source

Myasthenia gravis and thymoma: evaluation of 41 patients Miastenia grave e timoma: avaliação de 41 pacientes

open access: yesArquivos de Neuro-Psiquiatria, 1999
We evaluated the epidemiological, clinical, laboratory and therapeutical aspects of 41 patients with thymomatous myasthenia gravis. Thirty five patients (85.36%) were submitted to thymectomy. Follow-up ranged from two to 18 years.
JOSÉ LAMARTINE DE ASSIS   +3 more
doaj   +1 more source

Timectomia estendida por cirurgia torácica videoassistida e cervicotomia no tratamento da miastenia [PDF]

open access: yesJornal de Pneumologia, 2003
INTRODUÇÃO: A relação entre a miastenia e o timo é evidente e o tratamento atual desta condição inclui a timectomia. No entanto, uma revisão de nossa experiência com a timectomia revelou a necessidade do uso de uma técnica mais radical. OBJETIVO: Analisar retrospectivamente pacientes portadores de miastenia gravis que foram submetidos a timectomia ...
Acuff TE   +38 more
core   +4 more sources

Perioperative challenges and neuromuscular blockade concerns in robotic thymectomy for myasthenia gravis

open access: yesBrazilian Journal of Anesthesiology, 2020
Myasthenia Gravis (MG) is an autoimmune disease characterized by weakness and fatigability of skeletal muscles, with improvement following rest. It is a disease of great significance to the anesthesiologist because it affects the neuromuscular junction ...
Atish Pal, Vikas Gogia, Chetan Mehra
doaj   +1 more source

Results of surgical treatment for juvenile myasthenia gravis

open access: yesNeurología (English Edition), 2017
Introduction: Radical or extended thymectomy is an effective treatment for myasthenia gravis in the adult population. There are few reports to demonstrate the effectiveness of this treatment in patients with juvenile myasthenia gravis.
F.J. Vázquez-Roque   +5 more
doaj   +1 more source

The Italian Multicentric Study on the Prevalence of Vascular Calcifications and Vertebral Fractures in parathyroidectomised (PTX) Dialysis Patients (Cave PTX Study): Phase I Results [PDF]

open access: yes, 2014
Lo studio CAVE PTX ha lo scopo di valutare la reale prevalenza della paratiroidectomia nei pazienti dializzati in Italia, verificare l’aderenza ai targets ematochimici proposti dalle linee guida internazionali K/DOQI e ricercare la presenza di fratture ...
Conte, Carmina <1975>
core   +1 more source

Resultados del tratamiento quirúrgico en la miastenia gravis juvenil

open access: yesNeurología, 2017
Resumen: Introducción: La timectomía radical ampliada para el tratamiento de la miastenia gravis es una opción efectiva en la población adulta. No ocurre lo mismo en el caso de la miastenia gravis juvenil, ya que existen pocos reportes que demuestren su
F.J. Vázquez-Roque   +5 more
doaj   +1 more source

Primary adrenal insufficiency in adults: 150 years after Addison [PDF]

open access: yes, 2004
Thomas Addison first described, 150 years ago, a clinical syndrome characterized by salt-wasting and skin hyperpigmentation, associated with a destruction of the adrenal gland.
Alvarenga, Daniela B. de   +7 more
core   +4 more sources

Assessment of aprotinin in the reduction of inflammatory systemic response in children undergoing surgery with cardiopulmonary bypass [PDF]

open access: yes, 2010
OBJETIVO: Avaliar se a aprotinina em altas doses hemostáticas pode reduzir o processo inflamatório após circulação extracorpórea (CEC) em crianças. MÉTODOS: Estudo prospectivo randomizado em crianças de 30 dias a 4 anos de idade, submetidas à correção de
CARLOTTI, Ana Paula de Carvalho Panzeli   +7 more
core   +3 more sources

Home - About - Disclaimer - Privacy